Drug intelligence / Profile preview

(3R)-4,4-difluoro-3-[(4-methoxyphenyl)sulfonyl]butanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

(3R)-4,4-difluoro-3-[(4-methoxyphenyl)sulfonyl]butanoic acid is a synthetic small molecule belonging to the class of benzenesulfonyl compounds. It has been catalogued in chemical and drug databases as an experimental compound with no approved medical indications or known clinical use. The compound is characterized by its difluorinated butanoic acid backbone and a para-methoxybenzenesulfonyl substituent. There is no available information on its mechanism of action, biological targets, or therapeutic applications in humans[1][2][9].

Other names: (3R)-4,4-difluoro-3-(4-methoxybenzenesulfonyl)butanoic acid8MR

Beyond the preview

Go deeper on (3R)-4,4-difluoro-3-[(4-methoxyphenyl)sulfonyl]butanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (3R)-4,4-difluoro-3-[(4-methoxyphenyl)sulfonyl]butanoic acid.

Explore the full profile